HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne-Catherine Abel Selected Research

maytansinol

1/2022Maytansinol Derivatives: Side Reactions as a Chance for New Tubulin Binders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne-Catherine Abel Research Topics

Disease

3Neoplasms (Cancer)
01/2023 - 01/2021
1Lymphoma (Lymphomas)
12/2022
1Breast Neoplasms (Breast Cancer)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021

Drug/Important Bio-Agent (IBA)

3TubulinIBA
01/2023 - 01/2021
1PolymersIBA
01/2023
1IsoindolesIBA
12/2022
1ColchicineFDA LinkGeneric
12/2022
1Therapeutic UsesIBA
12/2022
1Tubulin ModulatorsIBA
12/2022
1maytansinolIBA
01/2022
1Cytotoxins (Cytolysins)IBA
01/2021
1compound 20IBA
01/2021
1Noscapine (Narcotine)IBA
01/2021

Therapy/Procedure

1Therapeutics
01/2022